NO882335L - Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener. - Google Patents
Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.Info
- Publication number
- NO882335L NO882335L NO882335A NO882335A NO882335L NO 882335 L NO882335 L NO 882335L NO 882335 A NO882335 A NO 882335A NO 882335 A NO882335 A NO 882335A NO 882335 L NO882335 L NO 882335L
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydrotiophenes
- tetrahydrofuranes
- acyloxymethyl
- ammonio
- omega
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878712693A GB8712693D0 (en) | 1987-05-29 | 1987-05-29 | Tetrahydrofurans etc |
Publications (4)
Publication Number | Publication Date |
---|---|
NO882335D0 NO882335D0 (no) | 1988-05-27 |
NO882335L true NO882335L (no) | 1988-11-30 |
NO170086B NO170086B (no) | 1992-06-01 |
NO170086C NO170086C (no) | 1992-09-09 |
Family
ID=10618139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO882335A NO170086C (no) | 1987-05-29 | 1988-05-27 | Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener |
Country Status (32)
Country | Link |
---|---|
US (1) | US5017588A (no) |
JP (1) | JPH0631228B2 (no) |
KR (1) | KR960005152B1 (no) |
AR (1) | AR243885A1 (no) |
AT (1) | AT395715B (no) |
AU (1) | AU610789B2 (no) |
BE (1) | BE1002146A3 (no) |
CA (1) | CA1317959C (no) |
CH (1) | CH674985A5 (no) |
DE (1) | DE3818106A1 (no) |
DK (1) | DK167532B1 (no) |
ES (1) | ES2009924A6 (no) |
FI (1) | FI89353C (no) |
FR (2) | FR2615735B1 (no) |
GB (2) | GB8712693D0 (no) |
GR (1) | GR1000147B (no) |
HK (1) | HK101790A (no) |
IE (1) | IE61341B1 (no) |
IN (1) | IN168799B (no) |
IT (1) | IT1219698B (no) |
LU (1) | LU87229A1 (no) |
MA (1) | MA21289A1 (no) |
MY (1) | MY103289A (no) |
NL (1) | NL192203C (no) |
NO (1) | NO170086C (no) |
NZ (1) | NZ224775A (no) |
OA (1) | OA08878A (no) |
PT (1) | PT87585B (no) |
SE (1) | SE466449B (no) |
SG (1) | SG93790G (no) |
TN (1) | TNSN88049A1 (no) |
ZA (1) | ZA883731B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8701727D0 (en) * | 1987-01-27 | 1987-03-04 | Scras | Tetrahydrofuran derivatives |
GB8712694D0 (en) * | 1987-05-29 | 1987-07-01 | Scras | Tetrahydrofurans etc |
ES2010568A6 (es) * | 1988-08-04 | 1989-11-16 | Uriach & Cia Sa J | Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano. |
ES2013834A6 (es) * | 1989-01-30 | 1990-06-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano. |
US5118708A (en) * | 1989-06-23 | 1992-06-02 | Norwich Eaton Pharmaceuticals, Inc. | Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents |
US20110097352A9 (en) * | 1992-01-29 | 2011-04-28 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
KR100326276B1 (ko) * | 1999-12-14 | 2002-03-08 | 정명식 | 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1088880A (en) * | 1964-11-18 | 1967-10-25 | Vantorex Ltd | ª‡-cycloalkyleneimino-substituted esters |
GB8701727D0 (en) * | 1987-01-27 | 1987-03-04 | Scras | Tetrahydrofuran derivatives |
GB8712694D0 (en) * | 1987-05-29 | 1987-07-01 | Scras | Tetrahydrofurans etc |
-
1987
- 1987-05-29 GB GB878712693A patent/GB8712693D0/en active Pending
-
1988
- 1988-05-20 AR AR88310910A patent/AR243885A1/es active
- 1988-05-20 NL NL8801315A patent/NL192203C/nl not_active IP Right Cessation
- 1988-05-23 IN IN455/DEL/88A patent/IN168799B/en unknown
- 1988-05-23 GR GR880100342A patent/GR1000147B/el not_active IP Right Cessation
- 1988-05-25 ZA ZA883731A patent/ZA883731B/xx unknown
- 1988-05-25 CH CH1980/88A patent/CH674985A5/fr not_active IP Right Cessation
- 1988-05-25 NZ NZ224775A patent/NZ224775A/en unknown
- 1988-05-26 SE SE8801964A patent/SE466449B/sv not_active IP Right Cessation
- 1988-05-26 GB GB8812488A patent/GB2205100B/en not_active Expired - Fee Related
- 1988-05-26 PT PT87585A patent/PT87585B/pt not_active IP Right Cessation
- 1988-05-26 MY MYPI88000561A patent/MY103289A/en unknown
- 1988-05-26 FI FI882475A patent/FI89353C/fi not_active IP Right Cessation
- 1988-05-27 LU LU87229A patent/LU87229A1/fr unknown
- 1988-05-27 TN TNTNSN88049A patent/TNSN88049A1/fr unknown
- 1988-05-27 DE DE3818106A patent/DE3818106A1/de active Granted
- 1988-05-27 JP JP63128593A patent/JPH0631228B2/ja not_active Expired - Lifetime
- 1988-05-27 MA MA21531A patent/MA21289A1/fr unknown
- 1988-05-27 CA CA000567990A patent/CA1317959C/en not_active Expired - Fee Related
- 1988-05-27 NO NO882335A patent/NO170086C/no not_active IP Right Cessation
- 1988-05-27 IT IT20773/88A patent/IT1219698B/it active
- 1988-05-27 ES ES8801674A patent/ES2009924A6/es not_active Expired
- 1988-05-27 BE BE8800600A patent/BE1002146A3/fr active
- 1988-05-27 DK DK291088A patent/DK167532B1/da not_active IP Right Cessation
- 1988-05-27 OA OA59367A patent/OA08878A/xx unknown
- 1988-05-27 AU AU16722/88A patent/AU610789B2/en not_active Ceased
- 1988-05-27 IE IE159988A patent/IE61341B1/en not_active IP Right Cessation
- 1988-05-28 KR KR1019880006343A patent/KR960005152B1/ko not_active IP Right Cessation
- 1988-05-30 FR FR888807164A patent/FR2615735B1/fr not_active Expired - Fee Related
- 1988-05-30 AT AT0140788A patent/AT395715B/de not_active IP Right Cessation
- 1988-05-30 FR FR888807163A patent/FR2615854B1/fr not_active Expired - Fee Related
-
1990
- 1990-02-27 US US07/485,448 patent/US5017588A/en not_active Expired - Fee Related
- 1990-11-19 SG SG937/90A patent/SG93790G/en unknown
- 1990-12-06 HK HK1017/90A patent/HK101790A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO883722L (no) | Fremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater. | |
NO882762D0 (no) | Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser. | |
NO880262L (no) | Fremgangsmaate for fremstilling av b avermectiner. | |
NO885454D0 (no) | Fremgangsmaate for fremstilling av triklormonosilan. | |
NO894210D0 (no) | Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. | |
NO894649D0 (no) | Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid. | |
NO880910D0 (no) | Fremgangsmaate for fremstilling av chromonderivater. | |
NO895032D0 (no) | Fremgangsmaate for fremstilling av 2-benzotiazoliner. | |
NO890159L (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler. | |
NO882730L (no) | Fremgangsmaate for fremstilling av aminocyklopentyletere. | |
NO170022C (no) | Fremgangsmaate for fremstilling av sialocylglycerolipider. | |
NO882335L (no) | Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener. | |
NO884900L (no) | Fremgangsmaate for fremstilling av ginkolid-derivater. | |
NO881713L (no) | Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere. | |
NO891985D0 (no) | Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater. | |
NO895040L (no) | Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer. | |
NO880834D0 (no) | Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer. | |
NO872199D0 (no) | Analogifremgangsmaate for fremstilling av alkoxyalkyl- og alkylmercaptoalkylsubstituerte benzofuroisokinoliner. | |
NO883398D0 (no) | Fremgangsmaate for fremstilling av benzoksazinderivater. | |
NO884100L (no) | Fremgangsmaate for fremstilling av halogentiazolderivater. | |
NO912279D0 (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. | |
NO890375L (no) | Fremgangsmaate for fremstilling av heksanitrostilben. | |
NO880844L (no) | Fremgangsmaate for fremstilling av cytotoksiner. | |
NO890819L (no) | Fremgangsmaate for fremstilling av hydroksybenzaldehyder. | |
NO871521L (no) | Fremgangsmaate for fremstilling av benzoksa- henholdsvis benzotia-diazolderivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |